Cibus, Inc. (NASDAQ: CBUS)
$2.4500
-0.1950 ( -5.04% ) 151.4K
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Market Data
Open
$2.4500
Previous close
$2.6450
Volume
151.4K
Market cap
$65.35M
Day range
$2.4000 - $2.8200
52 week range
$2.3700 - $23.1800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4/a | Other | 1 | Jun 03, 2024 |
10-q | Quarterly Reports | 94 | May 09, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
ars | Annual reports | 1 | Apr 19, 2024 |
def | Proxies and info statements | 19 | Apr 19, 2024 |
10-k | Annual reports | 128 | Mar 21, 2024 |
8-k | 8K-related | 14 | Mar 21, 2024 |
8-k | 8K-related | 15 | Mar 21, 2024 |
8-k | 8K-related | 14 | Mar 08, 2024 |
8-k | 8K-related | 14 | Jan 09, 2024 |